ArticleThe Journal of pharmacology and experimental therapeutics2017

A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.

Christof T Kaltenmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.